Research Paper Volume 15, Issue 8 pp 2937—2969
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
Figure 1. Expression of FARSB in HCC. (A) The expression level of FARSB in different types of tumor tissues and normal tissues in the TIMER database (p < 0.05). (B) Expression levels of FARSB in HCC tissues and adjacent by HCCDB datasets. (C) Expression levels of FARSB were higher than corresponding normal tissues in LIHC samples (TCGA-LIHC) (p=4.432e-25). (D) FARSB expression in 50 paired LIHC tissues and corresponding adjacent non-tumor tissues (TCGA-LIHC) (p=1.552e-14). (E) Expression levels of FARSB were higher than corresponding normal tissues in LIHC samples by using ICGC-LIRI-JP liver datasets (p<2.22e-16). (F) Expression levels of FARSB were higher than corresponding normal tissues in LIHC samples by using GEO GSE76427 liver cancer survival datasets (p=1.376e-04). (G, H) FARSB protein expression in normal and LIHC tissues (HPA).